COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value

被引：51

作者：

Gao, Yuan-Feng ^{[1
,2
]}

Mao, Xiao-Yuan ^{[1
,2
]}

Zhu, Tao ^{[1
,2
]}

Mao, Chen-Xue ^{[1
,2
]}

Liu, Zhi-Xiong ^{[3
]}

Wang, Zhi-Bin ^{[1
,2
]}

Li, Ling ^{[1
,2
]}

Li, Xi ^{[1
,2
]}

Yin, Ji-Ye ^{[1
,2
]}

Zhang, Wei ^{[1
,2
]}

Zhou, Hong-Hao ^{[1
,2
]}

Liu, Zhao-Qian ^{[1
,2
]}

机构：

[1] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410008, Hunan, Peoples R China

[2] Cent S Univ, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Changsha 410078, Hunan, Peoples R China

[3] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China

来源：

ONCOTARGET | 2016年 / 7卷 / 43期

基金：

中国国家自然科学基金;

关键词：

glioblastoma; novel glioblastoma markers; prognostic value; COL3A1; SNAP91; RANDOMIZED PHASE-III; GENE-EXPRESSION; RIBONUCLEOTIDE REDUCTASE; ADJUVANT TEMOZOLOMIDE; EXTRACELLULAR-MATRIX; MALIGNANT GLIOMAS; 5-YEAR ANALYSIS; SURVIVAL; CONCOMITANT; SUBTYPES;

D O I：

10.18632/oncotarget.12038

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Although patients with glioblastoma (GBM) have grave prognosis, significant variability in patient outcome is observed. This study aims to identify novel targets for GBM diagnosis and therapy. Microarray data (GSE4290, GSE7696, and GSE4412) obtained from the Gene Expression Omnibus was used to identify the differentially expressed genes (DEGs) by significant analysis of microarray (SAM). Intersection of the identified DEGs for each profile revealed 46 DEGs in GBM. A subset of common DEGs were validated by real-time reverse transcription quantitative PCR (qPCR). The prognostic value of some of the markers was also studied. We determined that RRM2 and COL3A1 were increased and directly correlated with glioma grade, while SH3GL2 and SNAP91 were decreased in GBM and inversely correlated with glioma grade. Kaplan-Meir analysis of GSE7696 revealed that COL3A1 and SNAP91 correlated with survival, suggesting that COL3A1 and SNAP91 may be suitable biomarkers for diagnostic or therapeutic strategies for GBM.

引用

页码：70494 / 70503

页数：10

共 43 条

[21] Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme [J].

Liang, Y ;

Diehn, M ;

Watson, N ;

Bollen, AW ;

Aldape, KD ;

Nicholas, MK ;

Lamborn, KR ;

Berger, MS ;

Botstein, D ;

Brown, PO ;

Israel, MA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (16) :5814-5819

[22] Commentary on Effects of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy Alone on Survival in Glioblastoma in a Randomised Phase III Study: 5-Year Analysis of the EORTC-NCIC Trial (Lancet Oncol. 2009;10:459-466) [J].

Linz, Ute .

CANCER, 2010, 116 (08) :1844-1846

[23] Variants of COL3A1 Are Associated with the Risk of Stroke Recurrence and Prognosis in the Chinese Population: a Prospective Study [J].

Lv, Wenfei ;

Lin, Yahui ;

Song, Weihua ;

Sun, Kai ;

Yu, Hui ;

Zhang, Yinhui ;

Zhang, Channa ;

Li, Liang ;

Suo, Miaomiao ;

Hui, Rutai ;

Chen, Jingzhou .

JOURNAL OF MOLECULAR NEUROSCIENCE, 2014, 53 (02) :196-203

[24] Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601) [J].

Mamelak, Adam N. ;

Jacoby, Douglas B. .

EXPERT OPINION ON DRUG DELIVERY, 2007, 4 (02) :175-186

[25] Health-Related Quality of Life in Elderly Patients With Newly Diagnosed Glioblastoma Treated With Short-Course Radiation Therapy Plus Concomitant and Adjuvant Temozolomide [J].

Minniti, Giuseppe ;

Scaringi, Claudia ;

Baldoni, Alessandra ;

Lanzetta, Gaetano ;

De Sanctis, Vitaliana ;

Esposito, Vincenzo ;

Enrici, Riccardo Maurizi .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02) :285-291

[26] Network analysis of adipose tissue gene expression highlights altered metabolic and regulatory transcriptomic activity in high-fat-diet-fed IL-1RI knockout mice [J].

Morine, Melissa J. ;

Toomey, Sinead ;

McGillicuddy, Fiona C. ;

Reynolds, Clare M. ;

Power, Karen A. ;

Browne, John A. ;

Loscher, Christine ;

Mills, Kingston H. G. ;

Roche, Helen M. .

JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2013, 24 (05) :788-795

[27] Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results [J].

Oike, Takahiro ;

Suzuki, Yoshiyuki ;

Sugawara, Ken-ichi ;

Shirai, Katsuyuki ;

Noda, Shin-ei ;

Tamaki, Tomoaki ;

Nagaishi, Masaya ;

Yokoo, Hideaki ;

Nakazato, Yoichi ;

Nakano, Takashi .

PLOS ONE, 2013, 8 (11)

[28] Glioblastoma and Other Malignant Gliomas A Clinical Review [J].

Omuro, Antonio ;

DeAngelis, Lisa M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (17) :1842-1850

[29] Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells [J].

Podergajs, Neza ;

Motaln, Helena ;

Rajcevic, Uros ;

Verbovsek, Urska ;

Korsic, Marjan ;

Obad, Nina ;

Espedal, Heidi ;

Vittori, Milos ;

Herold-Mende, Christel ;

Miletic, Hrvoje ;

Bjerkvig, Rolf ;

Turnsek, Tamara Lah .

ONCOTARGET, 2016, 7 (01) :593-609

[30] RETRACTED: MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene (Retracted Article) [J].

Qu, Shengtao ;

Yao, Yilong ;

Shang, Chao ;

Xue, Yixue ;

Ma, Jun ;

Li, Zhen ;

Liu, Yunhui .

PLOS ONE, 2012, 7 (09)

← 1 2 3 4 5 →